GlaxoSmithKline Plc, Johnson & Johnson and Sanofi are among drugmakers backing an effort to develop new vaccines that could be deployed swiftly to contain outbreaks before they spark global emergencies.

January 19th, 2017

Bloomberg

This entry was posted on Thursday, January 19th, 2017 at 1:09 pm and is filed under Global Health, Pandemic .
You can follow any responses to this entry through the RSS 2.0 feed.   Both comments and pings are currently closed.

Comments are closed.